Skip to main content
Top
Published in: Rheumatology International 9/2010

01-07-2010 | Short Communication

Association of cytosine–adenine repeat polymorphism of the estrogen receptor-β gene with rheumatoid arthritis symptoms

Authors: A. González-Canga, K. Ugai, M. Suzuki, H. Okuzawa, E. Negishi, K. Ueno

Published in: Rheumatology International | Issue 9/2010

Login to get access

Abstract

The influence of the polymorphism of the estrogen receptor-β gene, cytosine–adenine (CA) dinucleotide repeat in intron 6, in the occurrence of rheumatoid arthritis (RA) was investigated. Forty-seven RA patients and 36 control subjects with osteoarthritis (OA) were recruited. CA repeat polymorphism was examined using denaturing high-performance liquid chromatography (WAVE® DNA Fragment Analysis System). The mean number of CA repeats was significantly higher in RA than in OA patients. Two groups were established: ≤21 repeats (short S), ≥22 repeats (long L); and 3 kinds of genotypes (SS, SL, LL) were found. In RA patients, the L allele frequency was higher (OR = 2.03; P ≤ 0.05 Fisher’s test) and more subjects carried the LL genotype (OR = 5.50; P ≤ 0.05 Fisher’s test) compared to OA patients. It was concluded that the presence of the L allele could be a risk factor for RA, although additional larger scale study is needed.
Literature
1.
go back to reference Brooks PM (2006) Rheumatoid arthritis: aetiology and clinical features. Medicine 34:379–382CrossRef Brooks PM (2006) Rheumatoid arthritis: aetiology and clinical features. Medicine 34:379–382CrossRef
2.
3.
go back to reference Srikanth A, Deighton C (2006) Management of rheumatoid arthritis. Medicine 34:387–390CrossRef Srikanth A, Deighton C (2006) Management of rheumatoid arthritis. Medicine 34:387–390CrossRef
4.
go back to reference Combe B, Eliaou JF, Daures JP, Meyer O, Clot J, Sany J (1995) Prognostic factors in rheumatoid arthritis: comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 34:529–534CrossRefPubMed Combe B, Eliaou JF, Daures JP, Meyer O, Clot J, Sany J (1995) Prognostic factors in rheumatoid arthritis: comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 34:529–534CrossRefPubMed
6.
go back to reference Wolfe F (1997) The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic. Am J Med 103:12S–18SCrossRefPubMed Wolfe F (1997) The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic. Am J Med 103:12S–18SCrossRefPubMed
7.
go back to reference Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 93:5925–5930CrossRefPubMed Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 93:5925–5930CrossRefPubMed
8.
go back to reference Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49–53CrossRefPubMed Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49–53CrossRefPubMed
9.
go back to reference Forsell C, Enmark E, Axelman K, Blomberg M, Wahlund L, Jan-Åke G, Lars L (2001) Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer’s disease. Eur J Hum Genet 9:802–804CrossRefPubMed Forsell C, Enmark E, Axelman K, Blomberg M, Wahlund L, Jan-Åke G, Lars L (2001) Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer’s disease. Eur J Hum Genet 9:802–804CrossRefPubMed
10.
go back to reference Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378–383CrossRefPubMed Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378–383CrossRefPubMed
11.
go back to reference Nilsson M, Naessen S, Dahlman I, Linden Hirschberg A, Gustafsson JA, Dahlman-Wright K (2004) Association of estrogen receptor beta gene polymorphisms with bulimic disease in women. Mol Psychiatry 9:28–34CrossRefPubMed Nilsson M, Naessen S, Dahlman I, Linden Hirschberg A, Gustafsson JA, Dahlman-Wright K (2004) Association of estrogen receptor beta gene polymorphisms with bulimic disease in women. Mol Psychiatry 9:28–34CrossRefPubMed
12.
go back to reference Wang Z, Yoshida S, Negoro K, Kennedy S, Barlow D, Maruo T (2004) Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril 81:1650–1656CrossRefPubMed Wang Z, Yoshida S, Negoro K, Kennedy S, Barlow D, Maruo T (2004) Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril 81:1650–1656CrossRefPubMed
13.
go back to reference Sundarrajan C, Liao WX, Roy AC, Ng SC (2001) Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 86:135–139CrossRefPubMed Sundarrajan C, Liao WX, Roy AC, Ng SC (2001) Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 86:135–139CrossRefPubMed
14.
go back to reference Takeo C, Negishi E, Nakajima A, Ueno K, Tatsuno I, Saito Y, Amano K, Hirai A (2005) Association of cytosine–adenine repeat polymorphism of the estrogen receptor-β gene with menopausal symptoms. Gend Med 2:96–105CrossRefPubMed Takeo C, Negishi E, Nakajima A, Ueno K, Tatsuno I, Saito Y, Amano K, Hirai A (2005) Association of cytosine–adenine repeat polymorphism of the estrogen receptor-β gene with menopausal symptoms. Gend Med 2:96–105CrossRefPubMed
15.
go back to reference Negishi E, Takeo C, Nakajima A, Hisamitsu K, Hirai A, Ueno K (2006) Analysis of correlation between prescription drugs for climacteric disorders and CA repeat polymorphism of estrogen receptor beta gene. Jpn J Pharm Health Care Sci 32:21–26 Negishi E, Takeo C, Nakajima A, Hisamitsu K, Hirai A, Ueno K (2006) Analysis of correlation between prescription drugs for climacteric disorders and CA repeat polymorphism of estrogen receptor beta gene. Jpn J Pharm Health Care Sci 32:21–26
16.
go back to reference Kuklin A, Davis AP, Hecker KH, Gjerde DT, Taylor PD (1999) A novel technique for rapid automated genotyping of DNA polymorphisms in the mouse. Mol Cell Probes 13:239–242CrossRefPubMed Kuklin A, Davis AP, Hecker KH, Gjerde DT, Taylor PD (1999) A novel technique for rapid automated genotyping of DNA polymorphisms in the mouse. Mol Cell Probes 13:239–242CrossRefPubMed
17.
18.
go back to reference Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landén M, Jansson M, Holm G, Björntorp P, Eriksson E (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86:2562–2568CrossRefPubMed Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landén M, Jansson M, Holm G, Björntorp P, Eriksson E (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86:2562–2568CrossRefPubMed
Metadata
Title
Association of cytosine–adenine repeat polymorphism of the estrogen receptor-β gene with rheumatoid arthritis symptoms
Authors
A. González-Canga
K. Ugai
M. Suzuki
H. Okuzawa
E. Negishi
K. Ueno
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1423-4

Other articles of this Issue 9/2010

Rheumatology International 9/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.